default author photo

Timothy Rebbeck

Harvard University - Dana-Farber Cancer Institute

450 Brookline Avenue

Boston, MA 02215

United States

SCHOLARLY PAPERS

6

DOWNLOADS

502

TOTAL CITATIONS

3

Scholarly Papers (6)

Actions:
Email selected abstracts
1.

Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: A prospective cohort study

Number of pages: 72 Posted: 03 Mar 2022
Habib El-Khoury, David J. Lee, Jean-Baptiste Alberge, Robert Redd, Christian J. Cea-Curry, Jacqueline Perry, Hadley Barr, Ciara Murphy, Dhananjay Sakrikar, David Barnidge, Mark Bustoros, Houry Leblebjian, Anna Cowan, Maya I. Davis, Julia Amstutz, Cody J. Boehner, Elizabeth D. Lightbody, Romanos Sklavenitis-Pistofidis, Mark C. Perkins, Stephen Harding, Clifton C. Mo, Prashant Kapoor, Joseph Mikhael, Ivan Borrello, Rafael Fonseca, Scott T. Weiss, Elizabeth W. Karlson, Lorenzo Trippa, Timothy Rebbeck, Gad Getz, Catherine R. Marinac and Irene Ghobrial
Harvard University - Center for Prevention of Progression of Blood Cancers, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Biostatistics and Computational Biology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, The Binding Site Inc., The Binding Site Inc., Cornell University - Weill Cornell Medicine, Harvard University - Department of Medical Oncology, Mayo Clinic - Alix School of Medicine, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, The Binding Site Group Ltd., The Binding Site Group Ltd., Harvard University - Department of Medical Oncology, Mayo Clinic, City of Hope - City of Hope Cancer Center, Johns Hopkins University - Johns Hopkins Hospital, Mayo Clinic, Harvard University - Harvard Medical School, Harvard University - Harvard Medical School, Harvard University - Department of Biostatistics and Computational Biology, Harvard University - Dana-Farber Cancer Institute, Harvard University - Harvard Medical School, Harvard University - Department of Medical Oncology and Harvard University - Department of Medical Oncology
Downloads 157 (474,889)
Citation 3

Abstract:

Loading...

Multiple myeloma, monoclonal gammopathy, cancer screening, mass spectrometry

2.

Mass Spectrometry-Detected Monoclonal Gammopathy of Undetermined Significance is Associated with Obesity and Other Novel Modifiable Risk Factors: Results of the Promise Study

Number of pages: 29 Posted: 04 Jan 2023
David J. Lee, Habib El-Khoury, Angela C. Tramontano, Jean-Baptiste Alberge, Jacqueline Perry, Maya I. Davis, Erica Horowitz, Robert Redd, Dhananjay Sakrikar, David Barnidge, Mark C. Perkins, Stephen Harding, Lorelei Mucci, Timothy Rebbeck, Irene Ghobrial and Catherine R. Marinac
Harvard University - Department of Medical Oncology, Harvard University - Center for Prevention of Progression of Blood Cancers, Harvard University - Division of Population Sciences, Harvard University - Harvard Medical School, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Biostatistics and Computational Biology, The Binding Site Inc., The Binding Site Inc., The Binding Site Group Ltd., The Binding Site Group Ltd., Harvard University - Department of Epidemiology, Harvard University - Dana-Farber Cancer Institute, Harvard University - Department of Medical Oncology and Harvard University - Department of Medical Oncology
Downloads 129 (561,789)

Abstract:

Loading...

MGUS, Multiple Myeloma, plasma cell dyscrasia, risk factors

3.

Patient Preferences for Intervention in the Setting of Precursor Multiple Myeloma

Number of pages: 15 Posted: 11 Jun 2024
Catherine R. Marinac, Katelyn Downey, Jacqueline Perry, Brittany Fisher-Longden, Timothy Rebbeck, Urvi Shah, Elizabeth O'Donnell, Irene Ghobrial, Omar Nadeem and Brian Egleston
Harvard University - Department of Medical Oncology, Harvard University - Dana-Farber Cancer Institute, Harvard University - Department of Medical Oncology, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Harvard University - Dana-Farber Cancer Institute, Harvard University - Department of Medical Oncology, Harvard University - Dana-Farber Cancer Institute and Temple University - Fox Chase Cancer Center
Downloads 94 (720,278)

Abstract:

Loading...

prevention, interception, plasma cell disorder, precursor myeloma

4.

Associations of Fine Particulate Matter Pollution Components with Cause-Specific Mortality in Men with Prostate Cancer: A Cohort Study

Number of pages: 24 Posted: 30 Sep 2025
Hari S. Iyer, Marley Perlstein, Stefanie A. Joseph, Charlotte J. Roscoe, Nur Zeinomar, Alexander P. Cole, Fredrick R. Schumacher, Jennifer Beebe-Dimmer, Julie J. Ruterbusch, Charles L. Wiggins, Antoinette M. Stroup, Joel Schwartz, Jaime Hart, Timothy Rebbeck and Francine Laden
Rutgers University, New Brunswick - Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick - Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick - Rutgers Cancer Institute of New Jersey, Oregon Health and Science University, Rutgers University, New Brunswick - Rutgers Cancer Institute of New Jersey, Harvard University - Brigham and Women's Hospital, Case Western Reserve University, Wayne State University - Karmanos Cancer Institute, Wayne State University - Karmanos Cancer Institute, University of New Mexico, Rutgers, The State University of New Jersey - Rutgers University, Newark, Harvard University - Department of Environmental Health, Harvard University, Harvard University - Dana-Farber Cancer Institute and Harvard University
Downloads 48 (1,086,013)

Abstract:

Loading...

prostate cancer, cardiovascular disease, air pollution, air pollutants, environmental exposure, particulate matter

5.

Exercise to Enhance Cardiovascular Health Among Black Men with Prostate Cancer with Androgen Deprivation Therapy (The POWER Trial): A Study Protocol

Number of pages: 32 Posted: 09 Apr 2025
Dong-Woo Kang, Salvatore Ficarra, Rebekah L. Wilson, Alicia Morgans, Paul L. Nguyen, Timothy Rebbeck, David Einstein, Hajime Uno, Matthew Mossanen, Danielle M. Hill, Paola Gonzalo-Encabo, Mary K. Norris, John Gardiner, Darryl Tjogas, Jocelyn Greer and Christina Dieli-Conwright
Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University, Harvard University - Dana-Farber Cancer Institute, Harvard University, Harvard University - Dana-Farber Cancer Institute, affiliation not provided to SSRN, Harvard University - Beth Israel Deaconess Medical Center, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute and Harvard University - Dana-Farber Cancer Institute
Downloads 44 (1,157,785)

Abstract:

Loading...

Exercise, Prostate Cancer, Androgen Deprivation Therapy, Cardiovascular Disease, Randomized Controlled Trial

6.

Regular Aspirin Use and Mortality in Multiple Myeloma Patients

Number of pages: 19 Posted: 21 Jul 2021
Catherine R. Marinac, Graham A. Colditz, Timothy Rebbeck, Bernard Rosner, Mark Bustoros, Irene Ghobrial and Brenda Birmann
Harvard University - Department of Medical Oncology, Washington University in St. Louis - Division of Public Health Sciences, Harvard University - Dana-Farber Cancer Institute, Harvard University - Channing Division of Network Medicine, Cornell University - Weill Cornell Medicine, Harvard University - Department of Medical Oncology and Harvard University - Channing Division of Network Medicine
Downloads 30 (1,318,317)

Abstract:

Loading...